HCF RESEARCH FOUNDATION YEAR IN REVIEW 2017

2

ABOUT US

HISTORY OF THE HCF RESEARCH FOUNDATIONThe HCF Research Foundation, now in its 17th year, was established in 2000 as the HCF Health and Medical Research Foundation to fund health and medical research for the benefit of all Australians. In 2008, its focus shifted to health services research, an area of research that does not receive large funding dollars from other sources. In 2013, the name was simplified to the HCF Research Foundation.The HCF Research Foundation was originally established with a donation from the Hospitals Contribution Fund of Australia Limited (HCF). While HCF has continued to donate money, the HCF Research Foundation operates independently and with a specific focus on funding health services research that can benefit all 24 million Australians.

OUR MISSIONThe HCF Research Foundation’s mission is to encourage the examination and improvement of the provision, administration and delivery of health services to effect positive changes to the health of all Australians. This is achieved by funding research projects that consider the most effective ways to organise, manage, finance and deliver high-quality care; reduce the number of errors; and improve patient safety.

OUR VISION• To be known as an independent funder

of high-quality research, demonstrating that investment in research can help to improve the health of Australians.

• To be easy to deal with so that researchers are not subject to onerous requirements with regards to applications and reporting, but instead can focus on research.

• To be an organisation that helps to build the capacity of health services research by encouraging new researchers and service providers to partner with career researchers and develop sound project plans.

HEALTH SERVICES RESEARCHHealth services research examines how people access health care, how much health care costs, and what happens to patients as a result of this care.The HCF Research Foundation funds research and study proposals that use and enhance current knowledge to improve health care outcomes, the quality, efficiency, access to and equity of health service provision.The HCF Research Foundation’s research program addresses the main dimensions of the health system that are of concern to HCF, the HCF Research Foundation and the community at large, achieving better health outcomes and access to affordable, high-quality health care when and where needed.

HCF Research Foundation ABN 40 577 146 605

3

100% HEALTH SERVICES RESEARCHThe HCF Research Foundation is proud to be the only research foundation that commits 100% of its funding to health services research.

MESSAGE FROM THE CHAIR

Lisa M McIntyre Chair, HCF Research Foundation

In May the HCF Research Foundation, through its strategic partnership with the International Consortium for Health Outcomes Measurement (ICHOM), jointly hosted the inaugural ICHOM Australasian Forum.

The event sold out, with more than 350 delegates sharing the vision of the Foundation to better understand how we can embed Value Based Health Care in the Australian health care system.

The Foundation also expanded its research commitment with ICHOM this year through: • collaborating on the development of

an Overall Adult Health care outcome measurement tool, which recognises that individuals often have multiple health care conditions. This new approach will help doctors and patients better manage all conditions by uniformly collecting health care outcomes as reported by the patient

• commencing a project with Associate Professor Georgina Chambers from UNSW, which will evaluate the influence of models of care on the health and psychosocial outcomes of mothers and babies using the ICHOM Pregnancy and Childbirth measurement tool.

This year, we funded an additional eight teams to undertake research, including a study to reduce catheter-associated

urinary tract infections, a study to identify and reduce hospital-acquired malnutrition, and pharmacist-led home medicine reviews at an Aboriginal medical centre. In all, a further $1.1m in health services research grants were made available.

On top of this, in FY2017 we continued our successful partnerships with: • The Royal Australian College of

General Practitioners • The Australian Prevention

Partnership Centre • The George Institute for Global Health • and our HCF Research Foundation

Professorial Fellow, Professor Adam Elshaug.

To ensure we maintain focus on the Foundation’s mission, and to ensure we are meeting the needs of our researchers, the Foundation Board engaged the UNSW Social Policy Research Centre to undertake an independent review of our activities. The review demonstrated the value of the Foundation’s work, and reflected positively on the management of the Foundation’s Expression of Interest Program. The complete independent report is available on our website.

It has been a great year for the Foundation and our fellow researchers. We are proud of the positive relationships we have forged with Australian researchers, the medical workforce and their respective institutions to support the vision of the

HCF Research Foundation to deliver improved health care outcomes for all Australians.

2017 was a productive year for the HCF Research Foundation. This year we continued to entrench our mission by funding research and supporting the development of Value Based Health Care in Australia; we funded an additional $1.1m in health service research projects from our competitive expressions of interest program; and we undertook an independent review to ensure we were meeting our mission and our researchers’ expectations.

4

The HCF Research Foundation’s annual statutory report can be found at hcf.com.au/foundation.

STATEMENT OF FINANCIAL POSITION AS AT 30 JUNE 2017 2017 ($) 2016 ($)

AssetsCash and cash equivalentsDistribution receivablesFinancial assets at fair value through profit or lossTrade and other receivables

1,0232,026,44348,136,150

17,154

352,308968,258

48,657,9799,173

Total assets 50,180,770 49,987,718

LiabilitiesResearch grants payableTrade and other payables

2,338,09421,171

2,878,989

9,530

Total liabilities 2,359,265 2,888,519

Net assets 47,821,505 47,099,199

EquityTrust capitalRetained earnings

1,00047,820,505

1,00047,098,199

Total equity 47,821,505 47,099,199

FUNDS COMMITTEDThe HCF Research Foundation contributed $2.3 million in research funding in FY2017 to clinicians and researchers, who will work to understand and improve the effectiveness, efficiency and quality of health treatments and services in Australia.The HCF Research Foundation has invested $17.4 million in health services research since its inception in 2000.

HCF CONTRIBUTIONThe corpus of the Foundation has been funded by donations from the net surplus of the health fund. Since the Foundation’s inception in 2000, HCF has made contributions of $50 million.

FINANCIAL SNAPSHOT

RESEARCH GRANTS $1,886,415

ADMINISTRATION EXPENSES $171,480

5

INSTITUTIONS WE’VE PARTNERED WITH

6

449 Working Group members

21 Standard Sets developed

34 countries involved

10 Standard Sets in progressPictured: Thomas W Feeley, M.D. Senior Fellow at the Harvard Business School. Thomas headed the Institute for Cancer Care Innovation at the University of Texas MD Anderson Cancer Center until 2017.

7

IN THEIR WORDS• “The Forum allowed for our organisation

to gain a more global perspective of value- based health care and building of standard sets. It was very informative and the calibre of speakers was excellent.”

• “The keynote speakers were relevant and informative. The breakout sessions were very beneficial in explaining the challenges and opportunities faced when implementing Patient Reported Outcome Measurements.”

While ICHOM and its partners have developed standardised outcome sets across 21 medical conditions thus far, with another nine to be completed by the end of 2017, HCF has focused its collaboration on a more limited set of conditions where there is a high burden and/or evidence of potential for improvement.These conditions include Hip and Knee Osteoarthritis, Pregnancy and Childbirth, Oral Health and Overall Adult Health. We believe that systematic and patient- centred measurement of quality across these conditions is the first step towards better outcomes for thousands of Australians every year.With funding support from the HCF Research Foundation, these ‘Standard Sets’ are now being evaluated for feasibility and impact in Victoria (Hip and Knee Osteoarthritis) and New South Wales (Pregnancy and Childbirth). The research projects not only hope to build evidence to support investment in wider measurement, but also to generate important knowledge around the art and science of implementing outcome measurement across a variety of clinical settings. These evaluations will take into account both patients’ and carers’ perceptions, as well as clinical effectiveness.Early insights and results from this work were recently presented during the inaugural ICHOM Australasian Forum, which was organised by ICHOM in

conjunction with HCF, Ramsay Health Care and the New South Wales Agency for Clinical Innovation. The day-long event, which drew a capacity crowd of more than 350 people to the Shangri-La Hotel in Sydney, featured overarching plenaries from international experts, as well as breakout sessions focusing on topics critical to advancing value-based care in Australia.The HCF-supported project focusing on Hip and Knee Osteoarthritis was featured in a breakout session on implementation. In the session, Associate Professor Ilana Ackerman from Monash University and Bernarda Cavka, a physiotherapist at the Royal Melbourne Hospital, described how they have gone about collecting patient- reported outcome data (in areas such as mobility, pain and quality of life) in a high-volume public hospital, including challenges and key lessons learnt. Of note, the data being collected at the Royal Melbourne Hospital as part of this project is also being used to pilot the first global comparison of outcomes, which will facilitate learning and collaboration across 25 sites around the world. To date, the program has gathered data on approximately 5,300 procedures.For more information on ICHOM, visit ichom.org.

THE INAUGURAL ICHOM AUSTRALASIAN FORUM

As the topic of value-based care gains momentum globally, HCF continues to play a leading role in shaping the agenda and informing the direction of this critical transformation in Australia. Central to this work is HCF’s collaboration with the Boston-based and Harvard-affiliated International Consortium for Health Outcomes Measurement (ICHOM), which entered its second year in April. Together, HCF and ICHOM are working to define international standards for quality measurement and to evaluate the feasibility and impact of these standards in clinical practice.

FEEDBACK FROM THE FORUM84% of attendees were extremely or very

likely to recommend.92% felt they had a better understanding

of value-based health care as a result of attending.

8

THE RACGP FOUNDATION’S LATEST PROJECTS

PROFESSOR GEOFFREY MITCHELL, UNIVERSITY OF QUEENSLAND Development of a routine data collection process in community-based end-of- life care

THE PROBLEM We are living longer and dying differently. The population of Australia is ageing rapidly. While the need for increased specialist palliative care resources is well known and documented, in Australia we still know little about how and what palliative and end-of-life care is provided in the community setting (through primary care and GPs), or the quality of that care. That’s despite General Practice being required to carry more and more of the care towards end of life.

THE SOLUTION Professor Mitchell, together with Professor Claire Johnson and Dr Laura Deckx, will develop and test an end-of-life questionnaire that can be used to routinely collect data from GPs on end-of-life care – including information on causes of death, co-morbidities, location of care and death, symptom management techniques, service use and advance care planning. They then aim to test the questionnaire to see if it is the most feasible and effective way of capturing this data. Professor Mitchell was part of a successful RACGP/HCF grant in 2013 that identified the expectations of GPs, patients and carers at the end of life. They have also worked on a systematic literature review on GP end-of-life care. The results from these projects will contribute to questions in the questionnaire that indicate what patients and carers want from their GP at the end of life.

OVERALL AIM • A viable primary care end-of-life care register will provide

data that can be used for individual and practice-based quality improvement, as well as track changes in medical practice over time.

• The outcomes of this research will inform the development and implementation of a national primary care end-of-life care minimum dataset that includes routinely collected data on end-of-life management.

PROFESSOR PARKER MAGIN, UNIVERSITY OF NEWCASTLE AusTAPER Pilot: Team Approach to Polypharmacy Evaluation and Reduction (AusTAPER) pilot study for older General practice

THE PROBLEM The use of medicines has nearly doubled in Australia over the past 20 years, with ‘polypharmacy’ noted as a growing health concern. Medicines safety is a significant health issue for older Australians – they are at increased risk of adverse drug events (ADEs). ADEs are frequently under-recognised, and can be mistaken for symptoms that require further medication. Previous research by Professor Magin and his co-researchers has shown that older people are often exposed to potentially harmful medicines, which can have substantial clinical consequences.

THE SOLUTION There is now substantial evidence showing that older people can stop taking some medicines – reducing the number of medicines an older person takes can lead to better survival in the demographic.While the barriers and enablers of ‘deprescribing’ are now well documented in research, there is still a gap in translating this knowledge to advise GPs and patients to make informed decisions about what medicines they should be taking. Thanks to this grant from the RACGP Foundation and HCF Research Foundation, Professor Magin and his team at the University of Newcastle, the University of Western Australia, the University of Sydney and Central Queensland University will be piloting an approach to address the barriers doctors and patients face in ‘deprescribing’ medication (for patients, this includes fears of the original condition returning, and withdrawal effects). They will then evaluate how effective it is to bring together patient priorities and decision support tools to electronically flag potentially inappropriate medicines.

OVERALL AIM The study aims to determine the effect of the AusTAPER intervention in older people taking five medicines or more. This will be measured on three outcomes domains:• emergency presentations and/or unplanned hospital admission• wellbeing• health system costs.

9

THE CHILDREN’S HOSPITAL AT WESTMEAD APPENDICITIS STUDY

APPENDICITIS IN THE CHILDREN’S EMERGENCY DEPARTMENTAppendicitis is the most common reason for emergency surgery in children but is difficult to diagnose. Although abdominal pain is one of the most typical reasons for children presenting to an ED, almost 90% will not have acute appendicitis.For doctors, making a correct and early diagnosis is important because delayed diagnosis of appendicitis can lead to complications and potentially major consequences. However, this means that children are often over-investigated, with more invasive and expensive investigations performed.

TACKLING THE PROBLEMWhile various investigations and scoring systems have looked at ways to better diagnose appendicitis, little research has been done to work out which children have a risk level low enough to be sent home. Thanks to HCF Research Foundation funding, Dr McCaskill and her team at The Children’s Hospital at Westmead created a model of care using one of the best known and most studied decision rules for acute appendicitis (Paediatric Appendicitis Score, or PAS) to assess children presenting to the ED with possible appendicitis. The aim of the study was to understand if it is safe to discharge children aged between five and 16 who have signs

indicating a ‘low risk’ of appendicitis, with early follow-up with their own GP to check their progress. They looked at the risk of those children having to come back to hospital within 24 hours. Each child was assessed and scored on the elements such as the location of the pain and tenderness, nausea or vomiting, and fever, as well as blood test results for some children. The families involved in the study were contacted by phone to establish if they had returned to hospital within the following two weeks. They were also asked about their satisfaction with the care given. If children are in pain, or there is further concern from the family, they are advised to re-present to hospital immediately. The results show that it is safe to discharge patients at low risk of appendicitis with early planned review within 24 hours. For the child and their family, this means less time spent in hospital and less disruption. For the hospital, it relieves the load on surgical staff and reduces costs. The PAS score provides a common language between doctors so they can easily prioritise those patients who are at a higher risk. This successful model of care has the potential to be implemented at other hospitals, with the full potential realised if it were integrated as part of an agreed model of care between EDs across New South Wales and other states and territories across Australia.

Dr Mary McCaskill and her team at The Children’s Hospital at Westmead have developed a safe and effective model of care for children presenting to the emergency department (ED) with possible appendicitis.

KEY RESULTS

283 patients aged between five and 16 with abdominal pain and a low risk for appendicitis were enrolled in the study and discharged from ED.

Of the 8% who re-presented to hospital, five patients (1.7%) needed an operation, and four had appendicitis (1.4%).

92% of those sent home recovered at home without further hospital care.

10

ADAM ELSHAUGAdam Elshaug, PhD, MPH, is the HCF Research Foundation Professorial Research Fellow and Co-Director of the Menzies Centre for Health Policy (MCHP) at the University of Sydney. Adam sits on five national health care advisory panels, including as a Ministerial appointee to the Medicare Benefits Schedule (MBS) Review Taskforce. He has pioneered methods for measuring the prevalence of low-value care in administrative data sets, and regularly advises international governments, third-party payers and NGOs on enhancing the quality and efficiency of health system delivery and payment reforms.

THE LANCET RIGHT CARE SERIESFor the past three years to January 2017 Adam was co-lead of The Lancet ‘Right Care’ series of articles. In January 2017, this culminated in the publication of the series, containing four substantive papers and three commentaries (including one by Don Berwick), all focusing on the issue of low-value care. Adam was co-author on all four substantive papers (and lead author on the ‘Levers’ paper), as well as one of the commentaries. For more information see www.thelancet.com/series/right-care. Adam and the three other co-leads formally launched the series at The King’s Fund in London, in concert with the OECD and their report on waste in health care. Both the Right Care series and the OECD report were formal focal material for the OECD health ministers meeting taking place in Paris two weeks later.

MBS REVIEWProfessor Elshaug is a member of the MBS Review Taskforce. The MBS Review has met significant milestones in the latter part of 2017. Subject to the passage of legislation, the Minister for Health has announced that dozens of changes to the schedule will take place between November 2017 and March 2018. All are designed such that services can be aligned with contemporary clinical evidence and will improve health outcomes for patients.Examples include:• increasing the MBS rebate for selected

procedures performed by GPs• removing administrative blocks to allow

patients to claim MBS rebates for consultations with GPs during the ‘aftercare’ period

• blocking MBS items being claimed for subsequent attendances with any items in group T8 (surgical operations) that have an MBS fee of $300 or more

• changes to gastroenterology services• changes to MBS items for obstetrics

services• changes to ear, nose and throat MBS

items 41674, 41789, 41793 and 41801• changes to spinal x-ray services• changes to bone densitometry services.A full list of the latest changes, with additional detail, can be found at www.mbsonline.gov.au

KEY HIGHLIGHTSCo-lead of The Lancet ‘Right Care’ series of articles, of which were launched at The King’s Fund in London.

Currently sits on 5 national health care advisory panels, including as a Ministerial appointee to the MBS Review Taskforce.

2017 HIGHLIGHTSADAM ELSHAUG, PHD, MPH HCF RESEARCH FOUNDATION PROFESSORIAL RESEARCH FELLOW

11

PROJECT YEAR AMOUNT FUNDED

Professor Kate Curtis, the University of SydneyAn evidence-based approach to improving outcomes and reducing hospital-acquired complications in patients with rib fractures: Chest Injury Pathway (ChiP)

2016 $291,000

Associate Professor Georgina Chambers, UNSWEvaluating the influence of models of care on the health and psychosocial outcomes of mothers and babies 2016 $219,000

Associate Professor Brett Mitchell, Avondale CollegeReduction of catheter associated urinary tract infections in hospitals: a randomised study 2016 $171,000

Professor Ken Hillman, UNSWReducing inappropriate admissions and long hospital stays to improve health management for elderly patients

2016 $150,000

Natalie Simmance, St Vincent’s Hospital MelbourneIdentifying and reducing hospital-acquired malnutrition 2016 $86,000

Professor John Wheatley, Western Sydney Local Health DistrictRandomised controlled trial of a non-pharmacological integrated care intervention to reduce breathlessness in patients with severe or very severe chronic obstructive pulmonary disease (COPD)

2016 $60,000

Dr Jannine Bailey, Western Sydney UniversityPharmacist-led Home Medicines Review at Orange Aboriginal Medical Service: Implementation and Evaluation

2016 $48,000

Associate Professor Mark Gillett, Northern Sydney Local Health DistrictImpact of assessing and forwarding to GPs a Drug Burden Index in elderly patients discharged from Emergency Department

2016 $42,000

Dr Ilana Ackerman, Senior Research Fellow, the University of Melbourne Feasibility and costs of implementing the International Consortium for Health Outcomes Measurement Standard Set for hip and knee osteoarthritis.

2015 $150,000

Professor Gavin Andrews, Director and Professor of Psychiatry, St Vincent’s Hospital Sydney A low-cost accessible online program that improves the mental wellbeing of women experiencing depression and/or anxiety during the perinatal period

2015 $150,500

Dr Lynette Cusack, Research Fellow, the University of AdelaideEvaluating the costs and effectiveness of reduced length of stay for planned caesarean sections 2015 $46,333

Dr Kirtan Ganda, Endocrinologist and Research Fellow, Concord Repatriation General Hospital Improving the identification and management of patients with radiographically proven osteoporotic vertebral fractures

2015 $20,000

Professor Edward Janus, Head of General Medicine and Director of Research, Western HealthStandardising evidence-based interventions to shorten length of stay, reduce readmissions, reduce hospital costs and improve patient-reported outcomes for elderly patients in hospital with pneumonia

2015 $300,000

RECENT PROJECTS

12

PUBLICATION AND PRESENTATION HIGHLIGHTS FY2017

‘16 DR NICHOLAS ZDENKOWSKI‘Women’s experiences with a decision aid for neoadjuvant systemic therapy for operable breast cancer’, San Antonio Breast Cancer Symposium, San Antonio, USA, 9 December 2016, ‘Cancer Research 2016’;77.

DR NICHOLAS ZDENKOWSKIClinical Oncology Society of Australia/ Australia and New Zealand Breast Cancer Trials Group Annual Scientific Meeting 17 November 2016, Gold Coast – oral presentation entitled ‘Decision aids, patient views and barriers’ published in Asia-Pacific Journal of Clinical Oncology 2016;12 (Suppl. S12):66-168.

DR MARY McCASKILLAustralasian College for Emergency Medicine Annual Scientific Meeting (Queenstown, New Zealand) – poster presentation entitled ‘Investigating Appendicitis Score Study’, 21 November 2016.

DR NICHOLAS ZDENKOWSKIBreast Cancer in Young Women International Conference, Lugano, Switzerland – presentation entitled ‘Exploring how women make decisions on neoadjuvant systemic therapy (NAST) for operable breast cancer’, 11 November 2016, Breast 2016;29:S27.

DR NICHOLAS ZDENKOWSKIClinical Oncology Society of Australia/Australia and New Zealand Breast Cancer Trials Group Annual Scientific Meeting, 16 November 2016, Gold Coast – oral presentation entitled ‘Development and testing of a decision aid for women contemplating neo-adjuvant systemic therapy for operable breast cancer’. Asia-Pacific Journal of Clinical Oncology 2016;12 (Suppl. S12):66-168.

DR MARY McCASKILLAustralasian College for Emergency Medicine Annual Scientific Meeting (Queenstown, New Zealand) – abstract poster presentation entitled ‘Tummy Pain in Children – using a risk assessment tool’, 21 November 2016.

ASSOCIATE PROFESSOR ILANA ACKERMANNHMRC/Symposium on Research Translation (Melbourne) – poster presentation entitled ‘Implementing an ICHOM Standard Set to capture joint replacement outcomes’, November 2016.

DR MARY McCASKILLAustralasian College for Emergency Medicine Annual Scientific Meeting (Queenstown, New Zealand) – presentation entitled ‘Paediatric Appendicitis Risk Stratification’, 21 November 2016.

ADJUNCT ASSOCIATE PROFESSOR CHRISTOPHER PEARCEJMIR Research Protocols, Vol. 5, No. 4 – Using Patient Flow Information to Determine Risk of Hospital Presentation: Protocol for a Proof-of-Concept Study’, 20 December 2016.

13

‘17PROFESSOR GAVIN ANDREWSPerinatal Mental Health Seminar, 3 March 2017

PROFESSOR GAVIN ANDREWSMidwife meeting at the Royal Hospital for Women (Sydney), 9 March 2017.

PROFESSOR GAVIN ANDREWSChannel 7 media release, 18 March 2017.

ASSOCIATE PROFESSOR ILANA ACKERMAN‘The changing landscape of patient outcome assessment’ (editorial), Journal of Physiotherapy, Vol. 63, January 2017.

PROFESSOR EDWARD JANUSPresentation at Western Health Best Care Awards – ‘The routine application of patient- reported outcome measures in community- acquired pneumonia: A pilot feasibility study’, March 2017.

ASSOCIATE PROFESSOR ILANA ACKERMANICHOM Australasian Forum (Sydney) – podium presentation entitled ‘Putting outcomes measurement into practice: The Royal Melbourne Hospital experience’, ’May 2017.

ASSOCIATE PROFESSOR ILANA ACKERMANThe Australian – an interview with Tasker SJ entitled ‘Surgeons urged to adopt global standard, report results clearly’, 17 May 2017.

DR CHRISTOPHER FREEMANBMJ Open, Vol. 7 – ‘Reducing Medical Admissions into Hospital through Optimising Medicines (REMAIN HOME) Study: Protocol for a stepped wedge, cluster randomised trial’, 9 March 2017.

DR NICHOLAS ZDENKOWSKI‘A Decision Aid for Women Considering Neoadjuvant Systemic Therapy for Operable Invasive Breast Cancer: Development and Protocol of a Phase II Evaluation Study’, 28 April 2017 (ANZ1301 DOMINO), JMIR Research Protocols 2016;5(2):e88. doi: 10.2196/resprot.5641.

IAN A. HARRIS, JUSTINE M. NAYLORPublished paper entitled ‘Early mobilisation after total hip or knee arthroplasty: A multicentre prospective observational study, 27 June 2017.

IAN A. HARRIS, JUSTINE M. NAYLORPublished paper entitled ‘Evidence base and practice variation in acute care processes for knee and hip arthroplasty surgeries, 19 July 2017.

ASSOCIATE PROFESSOR ILANA ACKERMANPresentation on the ICHOM Standard Set for Hip and Knee Osteoarthritis Implementation Study to the Royal Melbourne Hospital Orthopaedic Department, June 2017.

PROFESSOR KEN HILLMANAnnual Showcase of the Ingham Institute for Applied Medical Research (Sydney) – oral presentation entitled ‘The Goals of Care: A new model of service for the dying older patient presenting at emergency services’, 7 June 2017.

14

Full details of the directors’ skills, experience and expertise can be found at hcf.com.au/foundation

THE BOARD

Lisa McIntyreBSc (Hons), PhD, GAICDDirectorMs McIntyre was appointed as a Trustee in 2013, became Chair in March 2014 and has been a Director of the Corporate Trustee since its registration in 2015.

Claire JacksonMBBS, MD, MPH, CertHEcon, GradCert Mgmt, FRACGP, FAICDDirectorProfessor Jackson was appointed as a Trustee in 2013 and has been a Director of the Corporate Trustee since its registration in 2015.

Helen LapsleyBA, MEc, FCHSMDirectorProfessor Lapsley was appointed to the Board of Directors of the Corporate Trustee in 2015.

John BarringtonBComm, LLB, FAICDDirectorMr Barrington was appointed to the Board of Directors of the Corporate Trustee in 2017.

Liz Rummery, AMBUniv (Hons)DirectorMs Rummery was appointed as a Trustee in 2009 and has been a Director of the Corporate Trustee since its registration in 2015.

Russell Schneider, AMGAICDDirectorMr Schneider was appointed as a Trustee in 2006 and has been a Director of the Corporate Trustee since its registration in 2015.

John Yu, ACMBBS, FRACP, FRACMADirectorDr Yu was appointed as a Trustee in 2013 and has been a Director of the Corporate Trustee since its registration in 2015.

Wayne AdamsBMath, GAICD, AFCHSMFoundation ManagerMr Adams has served as Foundation Manager since 2013.

MANAGEMENT

Luke GivneyLLB (Hons), GAICDCompany SecretaryMr Givney has served as Company Secretary of the Corporate Trustee since its registration in 2015.

COMPANY SECRETARY

1515

AUSTRALIAN CHARITIES AND NOT-FOR-PROFITS COMMISSIONThe HCF Research Foundation is regulated by the Australian Charities and Not-for-profits Commission (ACNC) and has been since the ACNC began in 2013. Further details about the ACNC can be found at www.acnc.gov.au.Its purpose is to maintain, protect and enhance public trust and confidence in the sector through increased accountability and transparency.

AUSTRALIAN COMPETITIVE RESEARCH GRANTS REGISTERThe HCF Research Foundation’s Health Services Research Grants Program is listed on the Australian Competitive Grants Register. The register lists granting schemes that provide competitive research grants to higher education providers. The income received by these providers from schemes listed on the register is used in allocating the Australian Government’s Research Block Grants.

REGISTRATION AND REGULATION

GO TOhcf.com.au/foundation

000000